This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
The leading UK pharmaceutical company, Glaxo Smithkline (GSK) announced new €2.2 million investment in Greece, at the British Residence.
2 October 2013
This investment will enable secondary packaging for 4 over-the-counter products. This will take place at FAMAR’s facilities, in the context of a long-term cooperation between the two companies. Production is expected to begin before the end of the year and will reinforce the exporting capacity of GSK Greece, as 98% of the new production will be exported to 32 countries.
The Minister for Development, Costis Hatzidakis, opened the event alongside the host, the British Ambassador, John Kittmer, who said:
I am delighted that GSK, a great British company, has decided to increase its investment in Greece. This decision shows the importance of foreign direct investment to Greece’s future and the importance of Greece’s efforts to improve the business environment.